2022年度研究發表

  

作者(順位) 論文題目 發表期刊
田宇峯(2) GRK3 AS A PROGNOSIS BIOMARKER IN GASTRIC CANCER

J.Cancer. 2022 Jan 31;13(4):1299-1306.

田宇峯(6) SHORT- AND LONG-TERM RECURRENCE OF EARLY-STAGE INVASIVE DUCTAL CARCINOMA IN MIDDLE-AGED AND OLD WOMEN WITH DIFFERENT TREATMENTS: A NATIONWIDE POPULATION-BASED COHORT STUDY Sci Rep: 2022 Mar 15;12(1):4422
田宇峯(4) Adipose Tissue-Derived CCL5 Enhances Local Pro-Inflammatory Monocytic MDSCs Accumulation and Inflammation via CCR5 Receptor in High-Fat Diet-Fed Mice. Int J Mol Sci: 2022 Nov 17;23(22):14226.
田宇峯(4) Impact of Tumor Location on Survival in Patients With Colorectal Cancer: A Retrospective Cohort Study Based on Taiwan's Cancer Registry Database Clin Med Insights Oncol: 2022 Jul 9;16:117955492211.
田宇峯(5) Augmented CCL5/CCR5 signaling in brown adipose tissue inhibits adaptive thermogenesis and worsens insulin resistance in obesity. Clin Sci (Lond): 2022 Jan 14;136(1):121-137
李健逢(4) Uncovering the Inhibitory Molecular Mechanism of Pomegranate Peel to Urinary Bladder Urothelial Carcinoma Using Proteomics Techniques. Life (Basel). 2022 Nov 9;12(11):1839. doi: 10.3390/life12111839.
田宇峯(5)
吳麗卿(9)
李健逢(11)
賴弘岳(C)
High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT. Pathol Res Pract. 2022 Nov;239:154158
田宇峯(2)
李健逢(11) 
Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy. Onco Targets Ther. 2022 Oct 11;15:1171-1181.
李宛珊(8)
李健逢(C) 
High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma. Oncology. 2022;100(9):485-497.
賴弘岳(2)
李宛珊(8)
李健逢(C) 
Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma. Onco Targets Ther. 2022 Jun 30;15:727-740.
李健逢(C)  Open the Technical Black Box of Tumor Mutational Burden (TMB): Factors Affecting Harmonization and Standardization of Panel-Based TMB. Int J Mol Sci. 2022 May 3;23(9):5097.
 李健逢(2) Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1. Cancers (Basel). 2022 Mar 31;14(7):1787.
賴弘岳(1)
吳麗卿(5)
李健逢(C)
High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis. Front Oncol. 2022 Mar 16;12:834249.
李健逢(C) Editorial: Molecular Mechanisms of Multiple Myeloma Front Oncol. 2022 Mar 16;12:834249.
 李健逢(C) Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression. Cells. 2022 Feb 11;11(4):638.
李健逢(10)  Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements. Mod Pathol. 2022 Jul;35(7):911-921
 李健逢(3) Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers. Clin Transl Med. 2022 Jan;12(1):e724.
賴弘岳(1)
吳麗卿(2)
龔柏勳(3)
李健逢(C)
High Level of Aristolochic Acid Detected With a Unique Genomic Landscape Predicts Early UTUC Onset After Renal Transplantation in Taiwan. Front Oncol. 2022 Jan 6;11:828314.
李健逢(10) Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions. Am J Surg Pathol. 2022 Jul 1;46(7):942-955.
李健逢(5) Myoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusions. Pathol Res Pract. 2022 Jan;229:153700.
賴弘岳(3) Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma. Clin Med Insights Oncol. 2022 Jul 22;16:11795549221113244.
李健逢(C) The biological impacts of CEBPD on urothelial carcinoma development and progression. Front Oncol. 2023 Jan 27:13:1123776.
李健逢(2,C) Autocrine gremlin 1, DAN family BMP antagonist in urothelial carcinoma. Cellular Oncology
李宛珊(1) High Expression of Folate Receptor Alpha (FOLR1) is Associated With Aggressive Tumor Behavior, Poor Response to Chemoradiotherapy, and Worse Survival in Rectal Cancer. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221141795
李宛珊(3) Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy. Onco Targets Ther. 2022 Oct 11;15:1171-1181.
田宇峯(5)
李宛珊(7)
Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cance Pathol Oncol Res. 2022 Oct 6;28:1610537
李宛珊(7) High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT. Pathol Res Pract. 2022 Nov;239:154158
龔柏勳(1)
吳麗卿(5)
李健逢(9)
Discrimination of Methicillin-resistant Staphylococcus aureus by MALDI-TOF Mass Spectrometry with Machine Learning Techniques in Patients with Staphylococcus aureus Bacteremia Pathogens. 2022 May 16;11(5):586.
廖乃鼎(1) 以3D列印嬰兒足後跟模型於醫檢人員採血OSCE應用成效探討 台灣擬真醫學教育期刊/2022/第八卷第一期/15
吳麗卿(5) Prevalence and Predictors of Insufficient Plasma Vitamin C in a Subtropical Region and Its Associations with Risk Factors of Cardiovascular Diseases: A Retrospective Cross-Sectional Study Nutrients: 2022 Mar 6;14(5):1108.
 吳麗卿(5) Suboptimal Plasma Vitamin C Is Associated with Lower Bone Mineral Density in Young and Early Middle-Aged Men: A Retrospective Cross-Sectional Study Nutrients:2022 Aug 29;14(17):3556